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1. Introduction 
The interest in automation technologies applied to anaesthesia has been grown 
exponentially in last decade. The main difference with other fields of automation is that the 
presence of a human supervisor has been never questioned. In spite of this, the use of 
automation tools to monitor and control the main variables during surgery notably helps 
the anaesthetist during surgery. The basic functions of the automation systems in 
anaesthesia are monitoring and control of the main variables of the process. This leads to 
two expected benefits. First, the anaesthetist will be freed of some routinary tasks so that he 
can concentrate more on the state of the patient. On the other hand, using these tools 
contributes to improve the global performance of the process in terms of safety, costs 
reduction and patient comfort. 
During the surgery operation three main variables have to be regulated: hypnosis, analgesia 
and muscle relaxation. To achieve this, drugs have to be properly administered to the 
patient. In recent years many efforts have been made in the development of new drug 
delivery technologies (Bressan et al., 2009). Most of the difficulties to calculate the proper 
drug rate to each patient were the inexistence of precise methods to monitor the anaesthetic 
state of the patient. In the past, patient monitoring was performed just by observing several 
patient signs (sweat, head lifting, movement, etc.). Nowadays the way that anaesthesia is 
monitored has changed considerably.  
Concerning hypnosis regulation, many efforts have been made to provide the 
anaesthesiologist with reliable methods for monitoring. In particular, the introduction of the 
Bispectral Index (BIS) to measure the depth of anaesthesia was one of the key elements in 
the development of new ways of drug administration (Sigl and Chamoun, 94). 
The other main problem in designing control algorithms to regulate hypnosis arises from 
the complexity of the patient response to drug infusion. This response can be divided in two 
subsystems. One is the Pharmacokinetics (PK) that refers to the adsorption, distribution, 
biotransformation and excretion of the drug. And the other is the Pharmacodynamics (PD) 
that describes the equilibrium relationship between concentration in the body and visible 
effect produced in the patient. In practice a linear model has been accepted to describe the 
PK and a nonlinear model for the PD part.  
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First works involved with anaesthesia control were focused in checking the performance of 
a fully automated controller compared with the results obtained in a process guided by an 
anaesthetist. In (Sakai et al., 2000) and (Morley et al., 2000) it is showed that proposed PID 
controller can assure intraoperative hemodynamic stability and a fast recover of the patient 
from the hypnosis effects of the drug using closed-loop techniques. In these works and in 
the works of Absalom (Absalom et al., 2002a, Absalom et al., 2002b, Absalom et al., 2003), it 
can be shown that the performance of the closed-loop system was as efficient as the 
observed in the process guided by the specialist, without demonstrating any clinical 
advantages over the manual techniques. 
In the last decade, a lot of research related with automatic control of anaesthesia has been 
made. Most of them use the intravenous drug propofol as the hypnotic agent. It is important 
to mention the works that follow a signal-based control, as PID (Liu et al., 2006; Dumont et 
al., 2009) and fuzzy controllers (Gil, 2004), and the works that follow a model-based control. 
In this way, many different proposals have been made depending on the controller 
structure, the controlled variable and the prediction model used. In (Struys. et al., 2001; 
Sawaguchi et al., 2003; Furutani et al., 2005) the drug concentration in brain is used as 
controlled variable. In (Ionescu et al., 2008) and (Niño et al., 2009), were EPSAC tecniques 
are used as controller structure, in (Screenivas et al., 2008), were robust characteristics are 
added in the design of the controller, and in (S. Syafiie et al., 2009), were nonlinear 
techinques are used, the authors use predictive control techniques. In (Screenivas et al., 
2009) a comparative study between predictive control and PID techniques applied to the 
control of anaesthetic is done. 
The focus of this chapter will be in the regulation of depth of consciousness of patients 
under general anaesthesia with intravenous propofol.  
2. Anaesthetic process: The control problem 
The main variables that describe the anaesthetic process are depicted in figure 1. In this 
figure an input-output description of the system is shown. As can be observed, manipulated 
variables are anaesthetics, relaxants or serums. Perturbations in the system are signals that 
can occur at any time (surgical stimulation, blood loss, etc.). The output variables can be 
measurable and not measurable. The main interest in anaesthesia is focused in non- 
measurable variables: hypnosis, analgesia and muscular relaxation. Although these 
variables are not directly measurable, there are methods to estimate them that are used in 
clinical practice. These methods are based on the use of alternative variables whose 
behaviour allows the estimation of the non-measurable ones. 
Hypnosis is a general term indicating loss of consciousness and absence of the memory of 
the intervention after awake. Currently, the techniques that have been considered more 
efficient for this are based in the processing of the patient electroencephalogram (EEG), 
(Kazama et al., 1999; Struys et al., 2000). 
The description of the BIS dynamics has been done mainly with physiological based models. 
These models consist of a PK part to describe the drug distribution in the internal organs 
and a PD part to describe the drug effect on the physiological variables of interest.  
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The drug distribution in the body depends on transport and metabolic processes, which in 
many cases are not clearly understood. However, dynamical models based on conservation 
laws that capture the exchange of material between coupled macroscopic subsystems or 
compartments, are widely used to model these processes.  
 
 
 
 
 
 
Fig. 1. Input-output description of the anaesthetic process. 
2.1 The compartmental model 
Figure 2 shows a model based in three compartments: central, fast and slow. The central 
compartment is the volume in which initial mixing of the drug occurs, and thus can be 
thought to include the vascular system (blood volume) and for some drugs the interstitial 
fluid. The fast peripheral compartment represents a compartment of the body that absorbs 
drug rapidly from the central compartment, and thus can be thought of as comprising 
tissues of the body that are well-perfused (such as muscles and vital organs). Finally the 
slow peripheral compartment is used to mathematically represent a compartment into 
which re-distribution occurs more slowly, and thus can be thought of as including tissues 
with a poor blood supply (such as adipose tissue). 
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Fig. 2. Compartmental model. 
The drug is infused in central compartment and then distributed to the slow and fast 
compartment and eliminated trough metabolism. Defining the drug concentration variable 
of the i-th compartment as Ci, the propofol distribution can be described as:  
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where u(t) represents the drug infusion rate in the central compartment and Vi is the volume 
of the i-th compartment. The dynamics of the compartmental model is defined by the 
following diffusion constants: k10 (rate constant for drug metabolism), k12 (rate constant for 
re-distribution of drug from central to fast peripheral compartment), k21 (rate constant for re-
distribution of drug from fast to central compartment), k13 (rate constant for redistribution of 
drug from central to slow compartment) and k31 (rate constant for redistribution of drug 
from slow to central compartment). Common PK models for propofol are the Marsh model 
(Marsh et al., 1991) and the Schnider model (Schnider et al., 1998). Differences between both 
models can be seen in table 1. 
From the point of view of hypnosis control, the variable of interest is not the blood 
concentration but the concentration in the place where the effect on the controlled variable is 
produced (effect site concentration). Thus, when there is a simultaneous measure of the drug 
concentration in blood and its effect on the brain, drug latency can be observed that produces a 
temporal displacement between the peak of blood concentration and the drug effect.  
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To include this dynamics in the model a fourth compartment is added. This compartment is 
known as effect site. It is assumed that this compartment is attached to the central 
compartment and has negligible volume. The diffusion constant of the effect site is ke0. 
 
 Marsh Model Schnider Model 
V1 0.228 L/Kg 4.27L 
k10(min-1) 0.119 
0.0443+0.0107*(BW-77)-0.0159*(LBM-
59)+0.0062*(HT-177) 
k12(min-1) 0.112 0.302-0.0056*(Age-53) 
k13(min-1) 0.0419 0.196 
k21(min-1) 0.005 1.29-0.024*(Age-53) 
k31(min-1) 0.0033 0.0035 
ke0(min-1) 1.21 0.456 
Table 1. Comparison of Marsh and Schnider models for PK of propofol. BW stands for Body 
Weight, LBM is Lean Body Mass and HT is Height. 
On the other hand, the drug’s pharmacodynamics, that represents the BIS in terms of the 
effect site concentration, is governed by:   
 ( )eBIS f C  (5) 
The f function is usually taken as an EMAX model whose profile suits the described process:  
 max
50
e
e
C
BIS BIS
C EC

      (6) 
 0BIS BIS BIS    (7) 
 max max 0BIS BIS BIS    (8) 
BIS0 corresponds to the awake state, BISmax represents the minimum achievable BIS and EC50 
represents the concentration in the effect site for which the effect is half the maximum value, 
 represents the sensitivity of the patient to mall concentration variations in the effect site. 
This parameter can be seen as index that measures the degree of nonlinearity of the model.  
2.2 The control problem 
From the perspective of the control system three level of complexity can be distinguished. 
The basic procedure is the open-loop practice in which the anaesthetist, according to the 
parameters of the patient (age, weight, sex, ASA) directly uses predefined infusion rates of 
drugs. According to the response observed through his vital signs the drug rates can be 
modified (the anaesthetist is the controller).  
In the next level, it appears the Target Controlled Infusion systems (TCI). In TCI the infusion 
rate is calculated from models of the pharmacokinetic of the patient, as can be seen in figure 
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3. Thus, the objective in TCI is to achieve a pre-set target plasma concentration. According to 
the model of the patient the TCI system (normally implemented in the infusion pump) 
delivers the adequate drug doses to achieve the objective. 
 
 
Fig. 3. Hypnosis control with TCI 
There is a clear weakness in TCI related to the fact that the real plasma concentration cannot 
be online measured to compute the infusion rate. That is, TCI is also an open-loop control 
strategy. Closed-loop strategies appear to solve this problem. The main idea in closed-loop 
control is to use information of the state of the patient to automatically adjust the drug 
dosing. Many efforts have been made to provide the anaesthetist with more reliable 
methods for monitoring this state. In particular, the introduction of the Bispectral Index 
(BIS) to measure the depth of anaesthesia was one of the key elements in the development of 
new ways of drug administration (Sigl and Manchoun, 94). BIS has been demonstrated to 
correlate well with the depth of consciousness of the patient. Thus, it can be used as a 
feedback system to the controller in order to compute the adequate infusion rate, as can be 
seen in figure 4. 
 
Fig. 4. Hypnosis control with closed-loop controller. 
The controller algorithm used for anaesthesia control can be based on signals or in models. 
Signal based controllers are basically PID algorithms. The key feature of this algorithm is 
that no model is necessary to compute the infusion rate. Instead, the measured BIS is used to 
compute an error signal from which the drug dose is calculated. Model based controllers are 
an alternative to PID controller. The advantage of model-based controller is its ability to 
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predict the behaviour of the patient and anticipate the changes in drug infusion to avoid 
undesirable responses. 
In order to develop an adequate model-based control strategy, it is necessary to obtain a 
suitable model for the patient behaviour. One common practice is to simplify the model 
by means of linear approximations around a nominal state (corresponding to BIS target). 
On the other hand, models are also necessary for offline simulation of the controller 
structure. The most accepted models for patient representation are those based on 
compartments to represent the pharmacokinetic together with a nonlinear modelling that 
describes the PD. 
3. Implementation of the closed-loop control of anaesthesia 
The main elements that constitute the control system are depicted in figure 5. As can be 
observed there is a computer that centralizes the monitoring and control task in the system. 
The BIS monitor is a passive analyser of EEG, that allows monitor the deep of anaesthesia, 
and has the first objective of adjust in real time the dose of drugs administered to one 
patient to the actual need. The BIS correlated well with the level of responsiveness and 
provided an excellent prediction of the level of sedation and loss of consciousness for 
propofol and midazolam. In this work the Aspect® A-2000 monitor was used. The 
communication with the computer was implemented via a RS-232 serial interface. 
Concerning the actuator, the Graseby® infusion pump was used for drug infusion in the 
patient. The pump is also governed via a RS-232 serial interface.  
 
 
 
Fig. 5. Main elements of the closed-loop control system. 
Apart from sending commands to the pump, the program in the PC reads continuously its 
state to detect eventual failures of any of the elements in the control loop, like missing BIS 
Patient Computer  
with monitor and 
control software 
Serial 
Interface 
Graseby 3500
Serial 
Interface 
Infusion of drug 
(propofol) 
Sensors 
EEG processing 
BIS calculation 
BIS Monitor
www.intechopen.com
 Pharmacology 
 
460 
signal, excessive infusion rate in the pump syringe changes, etc. The program in the 
computer has all the routines to monitor and control the system. 
The goal is to make a manual induction with propofol and remifentanil and maintain the 
BIS target during the maintenance of anaesthesia. Remifentanil infusion was adjusted 
manually and rocuronium was administered in bolus as needs. The operation conditions 
and the population in which the study was performed are explained in next section. 
4. PI control 
First control algorithm implemented was a PI controller. This algorithm has been 
extensively used in several automated closed loop systems. The administration of the drug 
is made based in the error between the BIS target and the current BIS, and the accumulated 
error during the operation. Both actions are regulated by gains, which are adjusted in an 
empirical way trying to get a smooth transitory and a stable response of the patient.  
The goal is to make a manual induction with propofol and remifentanil and maintain a BIS 
target during the maintenance of anaesthesia. Reminfentanil infusion was adjusted 
manually and rocuronium was administered in bolus as needs. In the real proofs, a BIS 
target (BISr) of 50 is considered while the measurement and actuation period is 5 seconds. 
Before starting its operation, the software checks that all the security alarms are 
programmed. 
This study was approved by the Ethical and Research Committee of the Hospital 
Universitario de Canarias and has written informed consent of the patients. The study was 
performed on a population of 15 patients of 30-60 years. In the real proofs with patients, a 
BIS target of 50 is considered while the measurement and actuation period is 5 seconds. 
Before starting its operation, the software checks that all the security alarms are 
programmed. In the operating room, the patient was connected to the BIS monitor, and the 
anaesthesia system was started in monitor mode. After the patient had breathed 100% 
oxygen for 3 min, the system was switched to manual mode, and anaesthesia was induced 
by means of nearly 2mg/Kg propofol manual bolus. Once the patient achieves a BIS closed 
to 50, the system is switched to automatic and the interest control algorithm is responsible to 
regulate the BIS around the objective. 
The adjustment of the controller gains was made in an empirical way trying to get a smooth 
transitory and a stable response. This task was done following standard procedures in 
online process control engineering. For this, it was necessary the presence of a control expert 
together with the anaesthesiologist in the operating theatre. Thus, after several trials 
adequate values for PI controller where found to be Kp=0.67, Ki=0.055. This set of values 
was tested in the whole population of the study with satisfactory results. Figures 6 and 7 
present the evolution of the anaesthesia for two different patients: patient 1 and patient 2. As 
can be observed, in both cases the system remains stabilised around the reference value with 
an oscillation of near 10 units in the worst case (patient 2).  
The results obtained with the population submitted to proofs show the patient remains 
stabilised around the reference value with an oscillation of near 10 units in the worst 
case. 
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Fig. 6. Results of anaesthesia automatic control on patient 1. 
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Fig. 7. Results of anaesthesia automatic control on patient 2. 
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The study revealed that although results are satisfactory, eventually the performance of the 
controller could decrease. There are two main factors that contribute to this. First of all, the 
variability between patients implies that the nominal PI parameters chosen are not the best 
choice for all the patients. Together with this, the dead time present in the system also 
contributes to reduce the phase margin of the closed loop system. The origin of this time-
delay is the period of time since the drug is infused until it causes the adequate effect in the 
patient. The main effect observed is that the evolution of the BIS is quite oscillatory (see 
figure 7) around the reference value. 
5. Dead-time compensation 
In previous section it can be viewed that PI controller usually gives a response with 
oscillations around the BIS reference value. In this section, the control algorithm is modified 
in order to compensate these oscillations and get a better transitory. The results shown in 
this paper are in simulation after having adjusted the patient dynamical model.  
The first method implemented to improve the results obtained with the fixed PI controller is 
to compensate the dead-time present in the system. To do this, a dead-time compensator 
based on the Smith Predictor theory (Smith, 72) is proposed to act with the PI controller. The 
basis of the Smith Predictor is to consider the feedback of the controlled variable BIS without 
delay. As this is variable is not available, the predictor estimates this value and uses this 
estimation as the feedback signal. To correct the deviations between this estimation and the 
real value, a correction term, resulting from the error between the estimation and the 
measured BIS, is added to the feedback signal, as can be seen in the figure 8. 
 
Fig. 8. PI Controller with Smith Predictor for patient hypnosis control. 
The basics of this compensation algorithm consider the formulation of the Smith Predictor 
for linear systems. To apply the Smith Predictor to the nonlinear model of the patient, a first-
order plus a time-delay approximation of the patient model is considered. A delay between 
90 and 120 seconds is considered.  
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5.1 Model adjustment 
In order to make the simulations proofs of the proposed algorithm, a physiology model of 
the patient dynamics was designed. As it was told, the model has two parts: 
pharmacokinetics and pharmacodynamics. The parameters adjustment was made in 
simulation using the real results obtained from a female, 56 years old patient, 84 Kg. weight, 
160 cm. height. 
After obtaining a satisfactory manual adjustment, the values for the pharmacokinetics 
model are k10=0.006, k12=11.0; k21=14.04, k13=10.02, k31=283.50 and ke0=0.0063. The 
values for the pharmacodynamics model are EC50=610.0, =1.5, BIS0 =100 and BISmax=0.  
To validate the model the simulated response is compared with the real one. The obtained 
results, shown in figure 9a), prove the goodness of the model. 
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Fig. 9. a) Simulated BIS output (dotted) and real patient BIS output (solid) obtained under 
the action of a PI controller. b) PI controlled output (dotted) and PI with delay-time 
compensation output (solid). 
5.2 Smith predictor (dead-time compensation) 
The proposal here is to improve the performance of the closed-loop system by means of a 
compensation of the system time-delay. The origin of this time-delay is the period of time 
between from the infusion pump starts until the drug is distributed along the central 
compartment. The majority of the works in the literature do not explicitly consider the 
presence of this time-delay in the proposed models. In fact, in model equations (1)-(4), time-
delay is not considered. But in real proofs, some delays between 1 and 2 minutes have to be 
considered to have a realistic model of the dynamics. Under this hypothesis, a time-delay 
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compensator based on the Smith Predictor theory has been proposed to be added to the PI 
controller. 
5.3 Results with PI controller with dead-time compensation 
As it is well known, the basics of this compensation algorithm consider the formulation of 
the Smith Predictor for linear systems. To apply the Smith Predictor to the nonlinear model 
of the patient, a first-order plus a time-delay approximation of the patient model is 
considered. Thus, the configuration employed can be seen in figure 8. A delay between 90 
and 120 seconds is considered in the simulations. In figure 9b the results obtained with the 
patient are shown. The evolution of the BIS signal with the Smith Predictor (in solid line) is 
much better than with the PI controller (in dotted line), and does not show oscillations 
around the reference BIS value. 
5.4 Self-adaptive dead-time compensation 
The main advantage of the time-delay compensation for the PI controller is a better 
performance in the transitory of the BIS signal. This advantage is conditioned to obtain a 
good fist-order approximation of the system. However, this model has to be changed in at 
least two situations. First, when the operation point changes due to a change in the BIS 
reference for the same patient. Second, when the controller is applied in a different patient, 
whose physiologic model has to be estimated. 
In order to improve the efficiency of that controller, an adaptation of the first-order model 
patient is added. The aim of this algorithm is to make the time-delay compensator 
independent of the model assumed for the patient. In order to obtain a simple adaptive 
algorithm that guarantees the closed-loop stability, model reference adaptive controller – 
MRAC- (Aström and Wittenmark, 94) is used, as can be seen in figure 10. 
 
Fig. 10. PI with Smith Predictor controller inserted in the adaptive control scheme MRAC. 
The error between the system output and the model reference output is used to update the 
parameters of the PI with Smith Predictor controller. 
Hypnosis 
_ 
+ 
Infusion 
pump 
+ 
_ 
Reference 
Model 
BISr(t) U(t)
BIS 
Monitor 
BIS(t)
PI + Smith 
Predictor 
Controller
Patient 
www.intechopen.com
 Closed-Loop Control of Anaesthetic Effect 
 
465 
Following this control scheme, the controller parameters are adjusted by an adaptation law 
that depends on the error between the system output (BIS) and the model reference output 
defined for this closed-loop. Minimising a certain cost-function involving this error, an 
adaptation law of the adjustable controller parameters is obtained. In this case, the 
adjustable parameters are the static gain and the time constant of the approximated first-
order model used in the Smith Predictor.  
5.5 Results with the PI controller with self-adaptive dead-time compensation 
Several simulation experiments has been made for the patient simulated in previous 
sections, choosing as the reference model a second-order model with poles, expressed in the 
z-plane discrete formulation, in z=0.98 and z=-0.75.  
The results are shown in figure 11a), where the evolution of the BIS under the self-adaptive 
compensator algorithm is drawn in solid line and compared with the results obtained in 
figure 9b) –PI and PI+compensator controllers-. In figure 11b) the evolution of the static gain 
under this self-adaptive scheme is shown. As it can be observed, some extra oscillations are 
produced with respect to the previous algorithm, which corresponds to the period of time in 
that the parameter is adapting.  
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Fig. 11. a) PI controlled system output (dotted), PI with Smith Predictor controlled output 
(dashed), and self-adaptive time-delay compensation controlled output (solid) compared for 
the same patient. b) Evolution of the static gain of the first-order approximation model of 
the time-delay compensation. 
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Once the optimal values for the parameters are reached, the performance of the system is 
very similar to the previous controller. In that case, the static gain took a value of -0.037. In 
this case, the stabilising value for this parameter is near the half. However, the performance 
is also satisfactory. Moreover, no assumptions over the system had to been made, which is 
the main advantage of this new algorithm. 
Comparing the results obtained with the previous algorithm, some extra oscillations are 
produced, which corresponds to the period of time in that the parameter is adapting. Once 
the optimal values for the parameters are reached, the performance of the system is very 
similar to the previous controller. Moreover, no assumptions over the system had to been 
made, which is the main advantage of this control algorithm. 
6. PI control with self-adaptive gains 
Another method to avoid the problem of the oscillations around the BIS reference value 
occurred with the PI controller is using an adaptive scheme to obtain the gains of the PI 
controller. The method is based on assuring a desired performance of the closed loop, by 
emplacing its poles as required, in order to obtain a smooth transition to the BIS reference 
value. 
This method is part of a kind of adaptive controllers, known as self-tuning regulators –STR-
(Aström and Wittenmark, 94). They are based on two steps. First, an identification of the 
system is made in order to get the dynamics in each instant of time. This assures that the 
controller takes into account the variations in the dynamics of the system. Second step is to 
compute the control law assuming that the identification results are true. The variety of STR 
schemes differs in the method used to compute the control law. In this work, an adjustable 
PI controller is used, which gains are tuned by trying that the closed loop performance of 
the system be as similar as possible to a desired reference model. This is obtained by 
emplacing the poles of the reference model into the desired values to get a satisfactory 
response of the system.  
STR controllers have two different parts. The most important part is that they provide an 
observer in order to identify the dynamics of the system to control. This is an essential point 
due to the results of the system identification are taken into account to compute the adaptive 
control law. In this case, a recursive least-squares method based is used to provide the 
parameters of the dynamics of the observed system.  
The second part of the controller is to compute the control law to apply to the system. The 
results of the identification part are taken to obtain the control action. In this way, the 
controller takes into account the variations of the dynamics of the system, if they occur. 
Another advantage of this scheme is its flexibility to be applied to different systems, with 
the same dynamics but with different parameters, because the identification process adapts 
the controller to the new situation. 
In this case, a pole placement controller is used. Considering the dynamics of the patient as 
a first order system, and using a PI controller with adaptive gains, the closed loop 
performance results in a second order system, which dynamics are set by emplacing its 
poles to the desired values for the closed loop system. Next subsections describe these two 
parts of the proposed controller. 
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6.1 Patient dynamics identification 
To obtain the dynamics of the patient, a stochastic recursive least-squares method is 
employed. It consists of an observer of the discrete system that tries to minimize the 
following cost function: 
 2
1
( )
2
J k  (9) 
where ε(k) is the residual error between the output of the system, BIS(k), and the observed 
model, being k the instant of time. 
Consider the following first order model as an approximation of the patient dynamics, with 
u(k) being the drug infusion rate of applied to the patient, and BIS(k) the BIS value obtained: 
 1 1( ) ( 1) ( 1)BIS k a BIS k b u k     (10) 
It can be expressed by: 
 ( ) ( )Ty k k   (11) 
  ( ) ( 1) ( 1) Tk BIS k u k      (12) 
  1 1 Ta b   (13) 
In each instant of time, the values of output and input of the system are measured. The 
iterative process to obtain the best parameters  that reproduce the performance of the 
patient is given by the equations: 
 ( ) ( ) ( ) ( 1)Te k y k k k     (14) 
 ( ) ( 1) ( ) ( ) ( )k k W k k e k      (15) 
where: 
 ( )
c
W k
k
  (16) 
being c a constant. 
6.2 Pole placement controller 
The control law considered for the system is obtained by applying a PI controller. This 
controller has two gains to adjust: the proportional gain, Kp, and the integer gain, Ki. The 
discrete version of this controller is given by: 
 
1
1( ) 1c
z
G k
z
  

   (17) 
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where the relation with the gains is given by: 
 
2p i
T
K K    (18) 
 
2p i
T
K K     (19) 
being T the sampling time of the system. Considering for the patient the model (10) and for 
the controller the expression (17), the poles of the closed loop are given by the roots of the 
following polynomial: 
  1 1 1 1 11 1( ) (1 )(1 )D z a z z b z z           (20) 
Consider the following specification for the closed-loop: 
 1 1 11 2( ) (1 )(1 )Q z q z q z
      (21) 
where q1 and q2 are the location of the desired poles for the system. It is easy to obtain from 
(20) and (21) the resulted gains of the PI controller: 
  1 2 1
1
1
1 q q a
b
      (22) 
  1 2 1
1
1
q q a
b
    (23) 
The parameters of the system are obtained in each instant of time form the identification 
process (15). With the values (22) and (23), the gains of the PI controller are obtained, using 
(18) and (19), by: 
 
2p
K
   (24) 
 iK
T
   (25) 
6.3 Results with the PI self-adaptive controller 
The results shown here correspond to a female of 40 years old, 70 Kg. weight and 170 cm 
height. The Schnider model presented in section 2 gives an accurate response with the real 
values obtained for the patient, where the following parameters for (6)-(8) equations are 
chosen: BIS0=95, BISmax=8.9, EC50=4.94 μg/ml and γ=2.69. Initially, the patient is infused 
with a bolus of 1.45 mg/Kg during 2 minutes in order to carry the patient near the desired 
value for the degree of hypnosis. The reference value is BISr=50. After that, the compensated 
adaptive controller starts controlling the system.  
To define the controller, the following assumptions are considered. First, the model for the 
patient is chosen as: 
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 ( ) 0.812 ( 1) 25.389 ( 1)BIS k BIS k u k      (26) 
For the second-order reference model, the poles are located in 0.997±0.0027j that correspond 
to a system with natural frequency 0.05 rad/sec and delta coefficient 0.75. For initiating the 
identification algorithm (15), the parameters used in (26) are chosen. c constant in (16) is set 
to 0.005. 
Figure 12 shows the evolution of the BIS and the parameters of the PI controller in this case. As 
it can be seen, after the application of the initial bolus, the PI controller varies its gains and the 
patient remains its degree of freedom around the desired value of 50, but with oscillations.  
 
Fig. 12. Results of the PI self-adaptive controller. First graph shows the BIS evolution with 
respect to BISr and second graph are the gains evolution of the PI controller. 
 
Fig. 13. Results of the compensated self-adaptive PI controller. First graph shows the BIS 
evolution with respect to BISr and second graph are the gains evolution of the PI controller. 
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To avoid these oscillations in the stationary, the compensation of the time delay by means of 
a Smith predictor is done in this case. To do that, the time delay considered is 1 minute. 
Figure 13 shows the results obtained in this case. The oscillations around the objective value 
are considerably reduced and the performance of the closed loop systems results better than 
in previous case. 
7. Model Predictive Control (MPC) 
As an alternative to signal based controllers proposed before, it is shown an algorithm that 
uses explicitly the model of the patient to compute the drug infusion rate. The objective is to 
improve the performance of other techniques as those based in PI controllers. Figure 14 
shows the structure of the proposed controller. As can be observed, the drug infusion rate is 
computed as a sum of two terms: 
 ( ) nu t u u   (27) 
The first term (un) is obtained by inverting the model of the patient and is computed to take 
the BIS variable to the nominal value (BISr=50, xn). That is, from the target BIS (BISr) and 
using the model of the patient (PK+PD) it can be obtained the infusion rate that leads the 
BIS signal to the desired value. To do this, the inverse dynamics of the system model is 
evaluated, assuming that the system is approximated by (1)-(5). Taking matrix notation for 
this model, it can be expressed by: 
 x Ax Bu    (28) 
where  1 2 3 Tex C C C C . 
 
 
 
Fig. 14. Structure of the proposed model-based predictive controller. 
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Assuming that the target state is an equilibrium state 1 2 3
T
n n n n enx C C C C    , the 
nominal input can be obtained by solving: 
 0n nAx Bu   (29) 
en
C  is computed by using the EMAX model (6), (7) and (8): 
 50
1
exp ln
1en
C EC  
         (30) 
with: 
 0
max 0
rBIS BIS
BIS BIS
    (31) 
Finally, to compute the nominal input nu  and the nominal state nx  equation (29) is solved 
to obtain the following solution: 
 1'nx M N
  (32) 
where 1 2 3'
T
n n n n nx C C C u     and: 
 
11 12 13 1
21 12 23 2
31 32 33 3
41 42 43 4
A A A B
A A A B
M
A A A B
A A A B
       
 (33) 
 
14
24
34
44
en
en
en
en
A C
A C
N
A C
A C
        
 (34) 
In Fig. 15, a simulation of the BIS in a patient with only this nominal input (un) is presented.  
As can be observed, the BIS tends to the nominal value (BISr=50) if only this input is applied. 
In practice, several considerations have to be taken into account. The first one is related to 
the modeling errors in the patient dynamics. In the simulation presented here no modeling 
errors were considered. In the real implementation, a deviation of the response of the 
system with respect to this ideal trajectory will be observed. On the other hand, as can be 
observed, the response exhibits a sluggish behavior that in real practice is undesirable. That 
is why this action is complemented with an additional term that tries to correct the 
deviations of the system from the nominal trajectory and also improves the transient 
response of the BIS curve.  
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Fig. 15. Simulation of the BIS in a patient applying only the nominal input un. 
This action is computed considering that the deviations of the BIS from the nominal value 
can be described by a linear approximation: 
 x A x B u     (35) 
 BIS C x D u     (36) 
where nx x x    and rBIS BIS BIS   .  
Then the control law uk can be obtained from an optimization problem (model based 
predictive controller). The problem can be formulated as obtaining the control law uk so 
that a specified cost function is minimized under a receding horizon strategy. Consider for 
example the following index: 
    
1
2 2
1 1
ˆ( ) ( ) ( | ) ( ) ( 1)
N NU
k
j j
J j w k j y k j t j u k j  
 
         (37) 
where N is the prediction horizon and NU is the control horizon. The problem is to find the 
sequence uk+j so that Jk is minimized. Assuming a receding horizon strategy, only the first 
value of the sequence is applied and the procedure is repeated at k+1. In this optimization, 
constraints can also be included, although the computational complexity is greatly 
increased.  
Figure 16 shows a simulation of this strategy. Initial condition was BIS=39. As can be 
observed, the response of the system is now much faster than that observed in figure 14 and 
achieves a very acceptable error quite soon.  
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Fig. 16. Simulation of the model-based controller of figure 14 on a patient. Nominal input 
(dashed line) and nominal+predictive controller (solid line). 
8. Conclusion 
In this chapter both results on modelling and control of patients under general anaesthesia 
with propofol is presented. First results presented refer to the synthesis of linear models for 
use in model-based controllers. The anaesthetic process was segmented into several phases, 
according to the state of the surgery (consciousness, hypnosis, intubation, incision, etc.). The 
propofol infusion rate in ml/h was used as the input variable u(t), while the BIS represented 
the output. Validation of the proposed model was done with real data patients.  
For simulation purposes a PK/PD model based on compartmental approaches as obtained. 
The model was adjusted using information of real data from patients. The obtained model 
was used to simulate the response of the patients with the different controllers.  
Concerning hypnosis control, this chapter presents a review of the state of the art of the 
closed-loop control of anaesthesia. Then, a description of approaches based on signal 
feedback and model based controllers are presented. 
The chapter proposed an advanced PI controller with several important features. First, an 
adaptive module is included that adapts the controller to the specific patient behaviour. On 
the other hand, the controller incorporates a dead-time compensation system that improves 
notably the performance of the controller. The performance of this compensation is 
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improved by self-adapting the approximation of the patient model used in the Smith 
Predictor scheme. 
The last part of the chapter is devoted to the design of model-based controllers. In 
particular, a model-based predictive controller is presented that corrects efficiently the 
transient evolution of the BIS, offering a smooth evolution of this signal to the reference 
value. 
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